Medtronic PLC MDT
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Medtronic PLC (MDT) Return on assets
Medtronic PLC's return on assets over the twelve months to 31 July 2026 was 5.68%, up 0.5 percentage points from fiscal 2026 (5.20%). Over the past ten years it has ranged from 3.25% (fiscal 2018) to 5.48% (fiscal 2022); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of −19.7% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Annual
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2026 | 5.20% | 0.07 |
| FY2025 | 5.13% | 1.07 |
| FY2024 | 4.06% | (0.07) |
| FY2023 | 4.13% | (1.35) |
| FY2022 | 5.48% | 1.56 |
| FY2021 | 3.92% | (1.39) |
| FY2020 | 5.31% | 0.20 |
| FY2019 | 5.11% | 1.86 |
| FY2018 | 3.25% | (0.79) |
| FY2017 | 4.04% | 0.61 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| DXCM DexCom, Inc. compare | 14.5% |
| BSX Boston Scientific Corporation compare | 8.47% |
| SYK Stryker Corporation compare | 7.91% |
| STE STERIS plc compare | 7.62% |
| EW Edwards Lifesciences Corporation compare | 7.35% |
| MDT Medtronic PLC | 5.68% |
| ABT Abbott Laboratories compare | 5.62% |
| GEHC GE HealthCare Technologies Inc. compare | 5.45% |
| PHG Koninklijke Philips N.V. compare | 4.21% |
| Medical Devices industry median | −19.7% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement